Chong Shen

Department of Urology, The Second Hospital of Tianjin Medical University

Affiliated withThe Second Hospital of Tianjin Medical University Tianjin Institute of Urology

Research Area

Biography

Chong Shen has not added Biography.
If you are Chong Shen and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients. Cancer medicine\| PubMed ID: 32250047	2020
Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer. Combinatorial chemistry & high throughput screening\| PubMed ID: 32940175	2021
Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer. Oncology reports\| PubMed ID: 33000254	2020
Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis. Acta histochemica\| PubMed ID: 34175686	2021
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway. Ecotoxicology and environmental safety\| PubMed ID: 35660381	2022
Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction. Disease markers\| PubMed ID: 35983409	2022
Corrigendum to "Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis" [Acta Histochem. 123(5) (2021) 151745]. Acta histochemica\| PubMed ID: 36180249	2022
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. Frontiers in oncology\| PubMed ID: 36300085	2022
CircSTK39 suppresses the proliferation and invasion of bladder cancer by regulating the miR-135a-5p/NR3C2-mediated epithelial-mesenchymal transition signaling pathway. Cell biology and toxicology\| PubMed ID: 36538242	2023
Construction and validation of a bladder cancer risk model based on autophagy-related genes. Functional & integrative genomics\| PubMed ID: 36689018	2023
Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS). Frontiers in cellular and infection microbiology\| PubMed ID: 36936777	2023
HP1α promotes the progression of prostate cancer. Molecular biology reports\| PubMed ID: 37014569	2023
circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response. Cell transplantation\| PubMed ID: 37026617	2023
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis. Frontiers in genetics\| PubMed ID: 37091788	2023
Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data. Heliyon\| PubMed ID: 37346342	2023
Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data. Functional & integrative genomics\| PubMed ID: 37358720	2023
Withdrawal notice to: "Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data" [Heliyon 9, (2023) 16897]. Heliyon\| PubMed ID: 37484247	2023
Construction and Validation of a Prognostic Model Based on Pyroptosis-related Genes in Bladder Cancer. Combinatorial chemistry & high throughput screening\| PubMed ID: 37849225	2024
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer. BMC medical genomics\| PubMed ID: 37880682	2023
Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. Frontiers in immunology\| PubMed ID: 37965307	2023
SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of bladder cancer. Translational andrology and urology\| PubMed ID: 38196702	2023
The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis. Heliyon\| PubMed ID: 38560150	2024
The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis. Technology and health care : official journal of the European Society for Engineering and Medicine\| PubMed ID: 39031404	2024
An integrated pan-cancer assessment of prognosis, immune infiltration, and immunotherapy response for B7 family using multi-omics data. Life sciences\| PubMed ID: 39034028	2024
Bioinformatics analysis of ERCC family in pan-cancer and ERCC2 in bladder cancer. Frontiers in immunology\| PubMed ID: 39192988	2024